S

Sironax at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Sironax brings 2 presentations to ObesityWeek 2026 in National Harbor. Its sessions focus on NAMPT activators for obesity. One shows pharmacologic NAMPT activation improving metabolism with weight-lowering effects in DIO mice, and another assesses the carcinogenicity risk of the NAMPT activator SIR4156 using a weight-of-evidence approach.

OrganizationObesityWeek 2026 Attendance
S
Sironax
Biotech
Biotech developing NAMPT activators, with obesity and metabolic disease among its programs.
Poster
Sat Nov 14
7:30pm–8:30pm
Weight-of-Evidence Carcinogenicity Risk Assessment of the NAMPT Activator SIR4156 in Obesity
Obesity pharmacotherapy and drug developmentMetabolism and integrative physiology

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Sironax

Tell us what you sell and we’ll find the people at Sironax most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction